138 related articles for article (PubMed ID: 38320219)
1. Interpretation of the EORTC-55954 Trial: Does the Response to Neoadjuvant Chemotherapy Have an Effect on Disease Outcome?
Mutlu Sütcüoğlu B; Sütcüoğlu O
J Clin Oncol; 2024 Apr; 42(10):1204-1205. PubMed ID: 38320219
[No Abstract] [Full Text] [Related]
2. Neoadjuvant chemotherapy for ovarian cancer: clarifying the confusion.
Wallach RC
Oncology (Williston Park); 2008 Nov; 22(13):1456; author reply 1456-7. PubMed ID: 19133602
[No Abstract] [Full Text] [Related]
3. Efficacy and safety results from GEICO 1205, a randomized phase II trial of neoadjuvant chemotherapy with or without bevacizumab for advanced epithelial ovarian cancer.
Garcia Garcia Y; de Juan Ferré A; Mendiola C; Barretina-Ginesta MP; Gaba Garcia L; Santaballa Bertrán A; Bover Barcelo I; Gil-Martin M; Manzano A; Rubio Pérez MJ; Romeo Marin M; Arqueros Núñez C; García-Martínez E; Gonzalez Martin A
Int J Gynecol Cancer; 2019 Jul; 29(6):1050-1056. PubMed ID: 31263024
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant therapy for ovarian cancer.
Imyanitov EN
Chin Clin Oncol; 2018 Dec; 7(6):54. PubMed ID: 30509076
[No Abstract] [Full Text] [Related]
5. Neoadjuvant chemotherapy in ovarian cancer.
Camci C; Balat O
Eur J Gynaecol Oncol; 2002; 23(5):437-41. PubMed ID: 12440820
[TBL] [Abstract][Full Text] [Related]
6. LTE-commenting on "Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer" (90: 163-9).
Eisenkop SM
Gynecol Oncol; 2004 Mar; 92(3):1017-8; author reply 1018-9. PubMed ID: 14984983
[No Abstract] [Full Text] [Related]
7. A case of bowel perforation after neoadjuvant chemotherapy for advanced epithelial ovarian cancer.
Carter J; Durfee J
Gynecol Oncol; 2007 Dec; 107(3):586-9. PubMed ID: 17949798
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy before definite operative approach for women with advanced-stage epithelial ovarian cancer.
Wang PH
Taiwan J Obstet Gynecol; 2018 Oct; 57(5):623-624. PubMed ID: 30342639
[No Abstract] [Full Text] [Related]
9. Neoadjuvant chemotherapy for advanced epithelial ovarian cancer.
Hall TR; Dizon DS
Clin Adv Hematol Oncol; 2016 Apr; 14(4):262-8. PubMed ID: 27166608
[TBL] [Abstract][Full Text] [Related]
10. CHRONO: randomized trial of the CHROnology of surgery after Neoadjuvant chemotherapy for Ovarian cancer.
Classe JM; Ferron G; Ouldamer L; Gauthier T; Emambux S; Gladieff L; Dupre PF; Anota A
Int J Gynecol Cancer; 2022 Aug; 32(8):1071-1075. PubMed ID: 35321888
[TBL] [Abstract][Full Text] [Related]
11. Comparison of adjuvant and neoadjuvant chemotherapy in the management of advanced ovarian cancer: a retrospective study of 574 patients.
Inciura A; Simavicius A; Juozaityte E; Kurtinaitis J; Nadisauskiene R; Svedas E; Kajenas S
BMC Cancer; 2006 Jun; 6():153. PubMed ID: 16759398
[TBL] [Abstract][Full Text] [Related]
12. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
[TBL] [Abstract][Full Text] [Related]
13. Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer.
Vergote I; Amant F; Kristensen G; Ehlen T; Reed NS; Casado A
Eur J Cancer; 2011 Sep; 47 Suppl 3():S88-92. PubMed ID: 21944035
[TBL] [Abstract][Full Text] [Related]
14. [Neoadjuvant chemotherapy in the treatment of ovarian cancer].
Lehoczky O
Orv Hetil; 2005 Sep; 146(38):1951-5. PubMed ID: 16238247
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy for epithelial ovarian cancer in Japan: a JSGO-JSOG joint study.
Machida H; Matsuo K; Enomoto T; Mikami M
J Gynecol Oncol; 2019 Nov; 30(6):e113. PubMed ID: 31576698
[No Abstract] [Full Text] [Related]
16. Neoadjuvant chemotherapy for advanced ovarian cancer: overview of outcomes and unanswered questions.
Onda T; Yoshikawa H
Expert Rev Anticancer Ther; 2011 Jul; 11(7):1053-67. PubMed ID: 21806329
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy for advanced epithelial ovarian carcinoma: a retrospective case-control study.
Vrscaj MU; Rakar S
Eur J Gynaecol Oncol; 2002; 23(5):405-10. PubMed ID: 12440812
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy in gynaecological cancers - Implications for staging.
Kumar L; Pramanik R; Kumar S; Bhatla N; Malik S
Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):790-801. PubMed ID: 25840650
[TBL] [Abstract][Full Text] [Related]
19. Surgical debulking before or after chemotherapy: stemming the tide on ovarian cancer recurrence.
Rueda BR; Tilly JL; Schorge JO
Onkologie; 2010; 33(6):286-7. PubMed ID: 20523089
[No Abstract] [Full Text] [Related]
20. [Neoadjuvant chemotherapy for advanced epithelial ovarian cancer].
Hatae M; Onishi Y; Nakamura T; Yamamoto H; Kusumoto M; Matsui T; Mihara K; Taniguchi H
Gan To Kagaku Ryoho; 2001 Nov; 28(12):1833-7. PubMed ID: 11729475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
